BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BINAXNOW COVID-19 AG CARD

    MDR report key: 14029756 · Received April 6, 2022

    Report

    Report Number
    1221359-2022-01962
    Event Type
    Malfunction
    Date Received
    April 6, 2022
    Date of Event
    January 10, 2022
    Report Date
    April 6, 2022
    Manufacturer
    ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
    Product Code
    QKP
    UDI-DI
    10811877011290
    PMA / PMN Number
    EUA202537
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    CA, US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    ADDITIONAL INFORMATION: 01471749-47. INVESTIGATION REPORT: ABBOTT DIAGNOSTICS (B)(4) INC. PERFORMED REVIEW OF MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING FOR KIT PART NUMBER 195-000 / LOT 166584 AND DEVICE PART NUMBER 195-430WL / LOT 154672. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 166584 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS (B)(4), INC. WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE. RELATED MFR REPORT NUMBERS: 1221359-2022-01916 THROUGH 1221359-2022-02048.

    Description of Event or Problem · 0

    CUSTOMER REPORTED ONE HUNDRED THIRTY-SEVEN (133) FALSE POSITIVE RESULTS WITH THE BINAXNOW COVID-19 AG CARD ON MULTIPLE DATES IN (B)(6) ON KITTED NASAL SWABS. THIS REPORT IS FOR PATIENT FORTY-SEVEN (47) OF ONE HUNDRED THIRTY-THREE (133) AND LOT 166584 (TOTAL QUANTITY 4). PATIENT WAS TESTED WITH THE BINAXNOW COVID-19 AG CARD ON (B)(6) 2022 WHICH GENERATED A POSITIVE RESULT. CONFIRMATION PCR NASAL SAMPLE WAS COLLECTED THE SAME DAY, PLACED IN VTM, AND TRANSPORTED VIA CURRIER TO A SEPARATE BRANCH LAB FOR TESTING (PLATFORM: PERKINELMER) WHICH GENERATED A NEGATIVE RESULT. THE PATIENT WAS SYMPTOMATIC. NO SERIOUS INJURY, MEDICAL INTERVENTION OR TREATMENT DECISIONS OCCURRED AS A RESULT. CUSTOMER IS PERFORMING TESTS IN COMMUNITY ORGANIZATIONS (COHORT 1: K-12 SCHOOLS INCLUDING FACULTY).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    825016 BINAXNOW COVID-19 AG CARD LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 166584 10811877011290

    Patients

    Seq Age Sex Outcome Treatment
    1 13 YR Male